A study presented at the 2016 American Society of Clinical Oncology Annual Meeting in Chicago found an antibody-based experimental therapy is lengthening the life-span of patients suffering from ...
A Ministry of Health, Labor and Welfare research team has announced the five-year survival rates for people diagnosed with ...
MedPage Today on MSN
FDA OKs Perioperative Immunotherapy for Stomach Cancer
The FDA approved perioperative durvalumab (Imfinzi) in combination with a multidrug chemotherapy regimen for resectable ...
With positive data from the Phase III HERIZON-GEA-01 study, Zymeworks and Jazz Pharmaceuticals will file an approval application for Ziihera in the first half of 2026 for the treatment of ...
Stomach cancer is one of the most problematic cancers because, at its early stages, symptoms are either nonexistent or very vague and easy to dismiss, like heartburn, indigestion, and feeling full or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback